secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2026-06-15T20:27:59+00:00
Accession:  0001628280-26-043210
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical stockholders approve reverse stock split, elect directors
--------------------------------------------------------------------------

- Reverse stock split amendment approved: 16,993,038 for, 6,597,036 against, 223,632 abstain.
- Class II directors Joseph Dawson and Joan Lau reelected with 9.8M and 9.9M votes for, respectively.
- Advisory vote on executive compensation passed: 8,232,918 for, 2,682,354 against, 96,595 abstain.
- Ratification of EisnerAmper LLP as auditor for 2026 approved: 22,996,530 for, 698,744 against.
- Reverse stock split intended to regain compliance with Nasdaq minimum bid price requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/rmti-20260612.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-043210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer